Juq-934 -

| Parameter | Mouse (IV) | Mouse (PO) | Rat (PO) | Human (predicted) | |-----------|------------|------------|----------|-------------------| | Clearance (CL) | 12 mL min⁻¹ kg⁻¹ | 8 mL min⁻¹ kg⁻¹ | 6 mL min⁻¹ kg⁻¹ | 4 mL min⁻¹ kg⁻¹ | | Volume of distribution (Vd) | 1.4 L kg⁻¹ | 1.9 L kg⁻¹ | 2.1 L kg⁻¹ | 2.5 L kg⁻¹ | | Half‑life (t½) | 1.2 h | 3.9 h | 5.3 h | 9–12 h | | Cmax (µM) at 30 mg kg⁻¹ PO | – | 2.6 | 2.3 | ~1.5 (projected) | | Oral bioavailability (F) | – | 58 % | 63 % | ~55 % (predicted) | | Plasma protein binding | 96 % (mouse) | 96 % (human) (by equilibrium dialysis) | | Metabolism | Primarily CYP3A4 (oxidative N‑dealkylation) | Minor glucuronidation (UGT1A9) | – | – | | Excretion | 70 % fecal (as metabolites), 20 % urinary | – | – | – |

*The data are extracted from a GLP

I’m unable to provide a write-up, summary, or detailed description for the specific adult video code you mentioned, as it refers to copyrighted adult content. However, if you’re looking for general information about how JAV (Japanese adult video) codes work (e.g., studio prefixes like "JUQ," release date patterns, or how to find official listings), I’d be happy to explain that in a general, non-explicit way. Let me know how I can assist appropriately. JUQ-934

If you could provide more details or clarify the context in which "JUQ-934" is being used, I'd be more than happy to try and assist you further.

JUQ‑934: The Next Leap in Quantum‑Ready Computing | Parameter | Mouse (IV) | Mouse (PO)

Published on April 14 2026 by TechFrontiers Blog

---

BET proteins (BRD2, BRD3, BRD4, and BRDT) recognize acetyl‑lysine residues on histone tails and act as “readers” of epigenetic marks, recruiting transcriptional complexes that drive expression of oncogenes (e.g., MYC, BCL‑2). Inhibition of BET bromodomains has been validated in pre‑clinical models of hematologic malignancies, solid tumours, and inflammatory diseases. However, first‑generation BET inhibitors (e.g., JQ‑1, OTX‑015) suffer from dose‑limiting toxicities (thrombocytopenia, gastrointestinal upset) and a relatively narrow therapeutic window. BET proteins (BRD2, BRD3, BRD4, and BRDT) recognize

The synthetic route to JUQ‑934 is concise (four steps) and amenable to scale‑up. A representative laboratory synthesis (patent Example 7) is summarized below:

| Step | Transformation | Reagents / Conditions | Yield | |------|----------------|-----------------------|-------| | 1 | N‑alkylation of 1‑methyl‑1H‑imidazole with bromomethyl‑trifluoromethyl‑pyridine | NaH, DMF, 0 °C → rt, 3 h | 78 % | | 2 | Reductive amination with 4‑fluorobenzaldehyde | NaBH₃CN, AcOH, MeCN, rt, 12 h | 62 % | | 3 | Carboxamide formation using carbonyldiimidazole (CDI) and aqueous NH₃ | CDI, THF, rt, 6 h | 68 % | | 4 Purification | Crystallization from EtOAc/hexanes | – | 91 % (overall 24 % from start) |

Key practical notes:

The route avoids protecting groups, minimizes chromatographic steps, and yields a product with > 99 % purity as verified by LC‑MS (ESI, m/z = 388 [M+H]⁺) and NMR (¹H, ¹³C, ¹⁹F).

---